Clinical Trial Update: Mechanisms of Glucose Lowering Effects of Sitagliptin and Metformin Alone and in Combination in Patients With T2DM [Phase 4]

View source ↗

Summary

Phase 4 study investigating the glucose-lowering mechanisms of sitagliptin and metformin, alone and in combination, in adults with type 2 diabetes mellitus; res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Sitagliptin (sitagliptin)
• metformin (metformin)

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Diabetes | Phase 4 | Status: COMPLETED | Results posted: 2013-12-13